Select Page

Updated Information To Reduce Potential Cardiac Surgery Infection Risks Associated With the LivaNova 3T Heater-Cooler Systems: FDA Safety Communication

Home Forums Infexion Connexion Updated Information To Reduce Potential Cardiac Surgery Infection Risks Associated With the LivaNova 3T Heater-Cooler Systems: FDA Safety Communication

 | Click to Receive Email Notifications of Posts
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #74870
    Glenys Harrington
    Participant

    Author:
    Glenys Harrington

    Email:
    infexion@ozemail.com.au

    Organisation:
    Infection Control Consultancy (ICC)

    State:

    Dear all,

    For this of you with LivaNova 3T Heater-Cooler Systems this FDA Safety
    Communication released on 19/10/2018 may be of interest.

    https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm623725.htm?utm
    _campaignA%20MedWatch%20-%203T%20Heater-Cooler%20Systems%20by%20LivaNova
    &utm_medium=email&utm_source=Eloqua

    Regards

    Glenys

    Glenys Harrington

    Infection Control Consultancy (ICC)

    P.O. Box 6385

    Melbourne

    Australia, 3004

    M: +61 404816434

    E: infexion@ozemail.com.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.